Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Wayne Cheng

Orthopaedic Surgery of the Spine Loma Linda, CA Medical Doctor

NPI 1699704023 CMS profile 122045

25915 Barton Rd Ste 203, Ste 203, Loma Linda, CA 92354

Open in the dashboard

General payments

$286,985

556 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$150,000

3 holdings reported · through program year 2025

Research they led as principal investigator

$59,350 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Wayne Cheng of Loma Linda, CA is reported in the CMS Open Payments database as having received $286,985 across 556 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $59,350 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $150,000 across 3 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 86th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $18,103 67
2024 General $20,401 93
2023 General $27,716 71
2022 General $145,941 61
2021 General $32,434 113
2020 General $28,439 62
2019 General $13,950 89
2021 Ownership $50,000 1
2020 Ownership $50,000 1
2019 Ownership $50,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Wayne Cheng
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Wayne Cheng were reported at $18,103. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Wayne Cheng Orthopaedic Surgery of the Spine median Middle half National median
2019 $13,950 $2,106 $337–$18,608 $163
2020 $28,439 $1,213 $156–$15,082 $114
2021 $32,434 $1,834 $271–$15,617 $132
2022 $145,941 $2,015 $320–$17,036 $149
2023 $27,716 $1,925 $336–$14,599 $160
2024 $20,401 $2,110 $341–$12,483 $164
2025 $18,103 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. DePuy Synthes Products, Inc. $143,283 12 payments
  2. Medtronic, Inc. $98,949 232 payments
  3. Medtronic USA, Inc. $16,269 28 payments
  4. Orthofix Medical, Inc. $15,534 14 payments
  5. Radius Health, Inc. $5,237 35 payments
  6. Abbott Laboratories $2,266 26 payments
  7. Amgen Inc. $1,139 68 payments
  8. DePuy Synthes Sales Inc. $734 32 payments
  9. Boston Scientific Corporation $594 15 payments
  10. Spinal Simplicity, LLC $441 4 payments
  11. Other $2,540 90 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Acquisitions $137,275 3 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $79,785 23 payments
  3. Consulting Fee $45,423 13 payments
  4. Food and Beverage $14,605 450 payments
  5. Travel and Lodging $9,717 58 payments
  6. Education $179 9 payments
Products named General payments · program years 2019–2025
  1. PIVOX Oblique Lateral Spinal System Tl $44,638 36 payments
  2. PIVOX Oblique Lateral Spinal System Tl $15,724 15 payments
  3. ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY $14,412 32 payments
  4. TDX Posterior Dynamic Stabilization $11,331 3 payments
  5. Phoenix CDX $11,250 2 payments
  6. Fibulink $9,791 2 payments
  7. PILLAR SA PTC Spacer System $7,200 1 payment
  8. PILLAR PL and TL PEEK Spacer System $7,200 1 payment
  9. Spinal Fixation System (SFS) $7,200 1 payment
  10. CD HORIZON SPINAL SYSTEM $6,353 16 payments
  11. Other $42,318 500 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

258

Median for Orthopedic Surgery: 203

Drug cost

$34,604

Median for Orthopedic Surgery: $1,433

Branded share of claims

48.1%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Evenity (2 Syringes) Romosozumab-Aqqg Brand 13 $30,860
Celecoxib Generic 44 $1,153
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 42 $726
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 40 $637
Cephalexin Generic 25 $544
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 29 $225
Oxycodone Hcl Generic 11 $172
Methylprednisolone Generic 27 $154
Gabapentin Generic 12 $90
Tramadol Hcl Generic 15 $43

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 68 billing codes

Paid by Medicare

$291,293

Medicare's payments for the services billed

Medicare patients

283

Average age 72

Services billed

1,168

168 women, 115 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 45%
Ischemic heart disease 31%
Chronic kidney disease 27%
COPD 26%
Depression 24%
Heart failure 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
EVENITY
  • Amgen Inc. $133
$133 13 —
Prolia
  • Amgen Inc. $117
$117 — —
DALVANCE
  • AbbVie, Inc. $35
$35 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

556 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record